Literature DB >> 33567955

A Systematic Review of Apathy and Depression in Progressive Supranuclear Palsy.

Joshua Flavell1, Peter J Nestor2,3.   

Abstract

Depression and apathy can be significant problems in progressive supranuclear palsy (PSP). Using PRISMA guidelines, this systematic review examined prevalence estimates for depression and apathy in PSP, and, how different methods of definition may influence results. 29 studies meeting inclusion/exclusion criteria were identified: 12 on depression, 9 on apathy, and 8 on both. Studies were stratified according to whether a diagnostic criteria, rating scale or screening question methodology was employed. The weighted mean prevalence was 59.7% for depression (sample size = 473) and 58.3% for apathy (sample size = 858). Results for depression using diagnostic criteria or rating scales were similar whereas screening questions were associated with considerable inconsistency. Depression prevalence appeared to be influenced by apathy but not somatic symptoms. Most apathy studies relied only on a screening question method. Depression and apathy are common in PSP but there is a need for consensus on how they are defined (both tools and cut-off scores). In particular, more studies probing apathy in greater detail than a simple screening question are required.

Entities:  

Keywords:  apathy; depression; progressive supranuclear palsy

Mesh:

Year:  2021        PMID: 33567955     DOI: 10.1177/0891988721993545

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  2 in total

1.  Imaging correlates of depression in progressive supranuclear palsy.

Authors:  Daniele Urso; Benedetta Tafuri; Roberto De Blasi; Salvatore Nigro; Giancarlo Logroscino
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 4.849

2.  Depression and Apathy across Different Variants of Progressive Supranuclear Palsy.

Authors:  Sarah M Bower; Stephen D Weigand; Farwa Ali; Heather M Clark; Hugo Botha; Julie A Stierwalt; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.